Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 16 of 16 publications.

Krege JH, Gilsenan AW, Komacko JL, Kellier-Steele N. Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates. J Bone Miner Res. 2022 Aug 14;6(9):e10665. doi: 10.1002/jbm4.10665

Gilsenan A, Midkiff K, Harris D, Kellier-Steele N, McSorley D, Andrews EB. Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study. J Bone Miner Res. 2020 Feb;36(2):244-51. doi: 10.1002/jbmr.4188

Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AL, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano C, Williams VSL, Vissing J, Zhang Auberson L, Wu M, de Vera A, Papanicolaou DA, Amato AA, RESILIENT Study Group. Safety and efficacy of intravenous bimagrumab in inclusion body myositis: a phase 2b, randomised, double-blind, placebo-controlled study (RESILIENT). Lancet Neurol. 2019 Sep;18(9):834-44.

Sheer R, Schwab P, Essex MN, Cappelleri JC, Reiners A, Bobula J, Pasquale MK. Factors related to the use of topical vs. oral NSAIDs for sprains, strains, and contusions in a senior population: a retrospective analysis of administrative claims data. Drugs Aging. 2018 Oct;35(10):937-50. doi: 10.1007/s40266-018-0585-8

Schwab P, Louder A, Li Y, Mallick R, Bays H. Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe. Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6

Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS, Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043

Andrews EB, Gilsenan AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res. 2012 Dec;27(12):2429-37. doi: 10.1002/jbmr.1768

Lukert B, Satram-Hoang S, Wade S, Anthony MS, Gao G, Downs R. Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study. Drugs Aging. 2011 Sep 1;28(9):713-27.

Do T, Wade S, Anthony MS, Wagman RB, Downs RW. Medication switching in postmenopausal women on osteoporosis therapy: six-month findings from the POSSIBLE US™ Study. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug 13; 23(S1):S468.

Tosteson ANA, Wade S, Anthony MS, Brancato C, Nichols S, Downs RW. Correlates of osteoporosis treatment persistence for patients new to therapy and patients with recent switches: 6-month results from POSSIBLE US. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug; 23(Suppl 1):S468.

Strader C, Shinoff CW, Fitzpatrick LA, Anthony MS. Burden of hip and wrist fractures: incidence estimates of non-traumatic fractures in older women in North America, Western Europe, Australia, and Japan. Poster presented at the 29th Annual Meeting of the American Society for Bone and Mineral Research; September 2007. [abstract] J Bone Miner Res. 2007 Sep; 22(Suppl 1):S118.

Anthony MS, Stephenson JJ, Long S, Lin SL. Low prevalence of bisphosphonate therapy among long-term glucocorticoid users. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 2006. Philadelphia, PA. [abstract] J Bone Miner Res. 2006 Sep; 21(Suppl 1):S281.

Anthony MS, Bradbury BD, Satia JA. Diagnosed osteoporosis: the tip of the iceberg. Poster presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research; August 2005. [abstract] J Bone Miner Res. 2005 Aug 11; 20(Suppl 1):S261.

Anderson JJB, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr. 1999 Apr;2(4):489-504.

Register TC, Anthony MS, Jayo MJ, Williams JK. Effects of 17ß-estradiol and consumption of phytoestrogen-rich soy or casein/lactalbumin-based diets on serum chemistries in ovariectomized female macaques. Poster presented at the 19th Annual Meeting of the American Society for Bone and Mineral Research; August 1997. [abstract] J Bone Miner Res. 1997 Aug; 12(Suppl 1):S350.

Jayo MJ, Anthony MS, Register TC, Rankin SE, Vest T, Clarkson TB. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys. Poster presented at the 18th Annual Meeting of the American Society for Bone and Mineral Research; August 1996. [abstract] J Bone Miner Res. 1996 Aug; 11(Suppl 1):S228.